Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations?

Table 1 Ongoing / completed human clinical trials for cardiac tissue engineering

Clinical trial name	Trial identifier	Target sample size	Status
Epicardial Infarct Repair Using CorMatrix®-ECM: Clinical Feasibility Study (EIR)	ClinicalTrials.gov Identifier: NCT02887768[32]	8	Completed
Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure (ESCORT)	ClinicalTrials.gov Identifier: NCT02057900[16]	10	Completed
Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial)	-	20	Completed
A Study of VentriGel in Post-MI Patients	ClinicalTrials.gov Identifier: NCT02305602[33]	15	Active, not recruiting
Clinical trial of human (allogeneic) induced pluripotent stem cell-derived cardiomyocyte sheet for severe cardiomyopathy	UMIN-CTR Clinical Trial ID: UMIN000032989[34]	3	Not yet recruiting